Insmed | INSM - Market Capitalization

Stock Price
164.70
Daily Change
2.27 1.40%
Monthly
15.07%
Yearly
141.89%
Q2 Forecast
157.54

Insmed reported $24.12B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025